Delivery Order SPE2DB20D3101-SPE2DB23FRFK8
- Not listed
- This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of Rifampin 300mg capsules, a pharmaceutical product, with a ceiling value of $106,743.73 and a performance period through June 18, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,954,752 units of Rifampin 300 mg capsules, with a ceiling value of $6,021.70 and a completion date of December 1, 2023. The contract is a Firm Fixed Price, Delivery Order type, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, one of the largest pharmaceutical distributors in the United States. The contract is for the delivery of Rifampin 300 mg capsules, a critical antibiotic medication, with a ceiling value of $2,148.60 and a completion date of September 25, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The contract is a firm fixed-price delivery order with a ceiling value of $3,992.80 and an ultimate completion date of February 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of Rifampin 300 mg capsules and has a ceiling value of $65,431.34. The contract has an ultimate completion date of February 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Rifampin capsules. The contract has a firm fixed price and a ceiling value of $86,447.52, with a period of performance ending on July 2, 2025. The contract is not set aside and was awarded on July 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Rifampin 300 mg capsules, a pharmaceutical product used to treat various bacterial infections. The contract has a ceiling value of $17,234.83 and a period of performance through March 25, 2025. It is a firm fixed-price contract, without any set-aside designation. AmerisourceBergen...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Rifampin 300 mg capsules. The contract is valued at $3,894.85 and has a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $1,024.77 and is a firm fixed-price, non-set-aside award with a period of performance through July 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) on February 13, 2024. The contract is for the supply of Rifampin 300 mg capsules and has a ceiling value of $15,215.32. It is a firm fixed-price contract with a performance period ending on February 14, 2024. The contract was not set aside for a specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRFK8Delivery Order
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4560298440 - Rifampin 300 mg capsules, with a ceiling value of $33,762.13 and a period of performance through March 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.8k | 3/17/23 |